Goldman Sachs Reiterates Sell Rating, $5 Price Target
https://www.benzinga.com/news/21/03/20260415/clovis-oncology-shares-move-lower-hearing-goldman-sachs-reiterates-sell-rating-5-price-target
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.